Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
FITC-Dextran 70 (AC173)
Cat.#: ASSD-173
Specifications
Description FITC I dextran is dextran labeled with fluorescein isothiocyanate for possible use to study the capacity, selectivity, and efficiency of encapsulation and release by drug delivery vehicles. Synonyms FITC-Dextran 70 is also known as Fluorescein isothiocyanate–dextran. Size 100 mg, 500 mg Applications Dextran labeled with fluorescein isothiocyanate. Used for possible use in live animals imaging. Molecule Weight ~70,000 CAS Number 60842-46-8 MDL Number MFCD00131092 Solubility Soluble in water (50 mg/mL--hazy, orange to very deep orange). Excitation 492 nm Emission 512 nm Storage Desiccate at 4° C Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ASSD-219 Tetramethylrhodamine-6-maleimide (AC219) 5 mg inquiry ASSD-142 Methoxy-X04 (AC142) 10 mg, 50 mg inquiry ASSD-208 NBD-X, succinimidyl ester (AC208) 100 mg inquiry ASSD-218 6-Carboxy-2′,7′-dichlorofluorescein-3′,6′-diacetatesuccinimidyl Ester (AC218) 25 mg inquiry ASSD-130 Calcein-AM (AC130) 1 mg inquiry ASSD-170 BAPTA-AM (AC170) 25 mg inquiry ASSD-217 t-Boc-MTSEA-Fluorescein (AC217) 10 mg inquiry ASSD-119 Fluorescent adenosine agonist [NECA] (AC119) 500 μg inquiry ASSD-175 5-Carboxyfluorescein-N-hydroxysuccinimide Ester (AC175) 25 mg inquiry ASSD-117 Annexin V-PE Apoptosis Staining / Detection Kit (AC117) 1 kit, 100 tests inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket